SOLICITATION NOTICE
B -- Tuberculosis Trails Consortium (TBTC) Study for Pulmonary Tuberculosis
- Notice Date
- 7/22/2008
- Notice Type
- Presolicitation
- NAICS
- 541990
— All Other Professional, Scientific, and Technical Services
- Contracting Office
- Department of Health and Human Services, Centers for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, Georgia, 30341-4146
- ZIP Code
- 30341-4146
- Solicitation Number
- 200-2003-01441
- Response Due
- 8/6/2008
- Archive Date
- 8/21/2008
- Point of Contact
- Zalerie P Moore, Phone: 770-488-2053, Michele D. Jackson ,, Phone: 770-488-2425
- E-Mail Address
-
fkw7@cdc.gov, mnj7@cdc.gov
- Small Business Set-Aside
- N/A
- Description
- In accordance with 41 U.S.C. 253(c)(1) and FAR 6.302(1), the Centers for Disease Control and Prevention (CDC) intends to issue a sole-source, cost reimbursement modification to Case Western Reserve University, in Cleveland, OH under contract 200-2003-01441. The Tuberculosis Trails Consortium TBTC is a collaboration of clinical investigators in the United States and multiple other nations whose mission is to conduct programmatically relevant clinical, laboratory, and epidemiologic research concerning the diagnosis, clinical management, and prevention of tuberculosis infection and disease. The consortium presently includes study sites in the U.S., Canada, Brazil, Spain, Uganda and the Republic of South Africa. The TBTC has conducted clinical trials in tuberculosis for over a decade, and has become an influential research resource globally. The Case Western Reserve University/Kampala Uganda site has one of the few certified laboratories that are essential for conducing Study 29. TBTC Study 29 is a prospective, multicenter, open-label clinical study for adults suspected of having pulmonary tuberculosis. The TBTC Study 29 Phase 2 clinical trial is to evaluate the antimicrobial activity and safety of an experimental intensive phase tuberculosis treatment regimen. The University will provide all necessary services, qualified personnel, material, equipment, and facilities to perform Study 29, using procedures outlined in the applicable protocol. The University will enroll, treat, perform laboratory tests, perform clinical follow-up, and report information on the appropriate case report forms to the CDC. The Case Western Reserve University/Kampala Uganda site has had the largest number of enrollments for Study 29 during the past two (2) studies which is necessary to meet the CDC requirements. Interested parties who feel that they possess the capabilities to provide the services described above should submit a capability statement demonstrating their capabilities to provide the services. The information received in response to this notice will be considered solely for the purpose of determining whether or not to conduct a competitive procurement. Please send your documentation to Michele D. Jackson at the office identified above, by fax (770) 488-2688 or email to mnj7@cdc.gov. Documentation should be received within fifteen (15) days after the date of publication of this synopsis to be considered by CDC. A determination by the CDC not to compete this proposed contract based upon responses to this notice is solely within discretion on of the Government.
- Web Link
-
FedBizOpps Complete View
(https://www.fbo.gov/?s=opportunity&mode=form&id=f8b591a382d70b5ba2c9298ca6d02596&tab=core&_cview=1)
- Place of Performance
- Address: Kampala, Uganda, Uganda
- Record
- SN01619984-W 20080724/080722223616-f8b591a382d70b5ba2c9298ca6d02596 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |